Literature DB >> 8894849

Genetic models in the study of anesthetic drug action.

V J Simpson1, T E Johnson.   

Abstract

This chapter reviews the use of genetic models in the study of anesthetic drug action. Genetic model systems provide a novel approach to understanding mechanisms of anesthetic drug action. Many models have been derived using selection processes that emphasize differential drug sensitivity, producing animal lines that differ in their CNS drug response. Studies of vertebrate (rodent) and invertebrate (Drosophila, Caenorhabditis elegans) animal model systems are covered. The review discusses studies employing lines derived from spontaneous and induced mutagenic processes, selectively bred lines, and inbred lines possessing inherent differential drug sensitivities. The primary focus of included studies is the general anesthetic drugs that are commonly used in the clinical setting. These are drugs such as the inhalational agents (halothane, enflurane, isoflurane, nitrous oxide) and the intravenous induction agents (propofol and diazepam). Rodent lines with differential sensitivity to opiates are also discussed. Finally, an approach to identifying and isolating the genes that control anesthetic sensitivity is discussed in a section on mapping quantitative trait loci (QTL) in recombinant inbred lines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894849     DOI: 10.1016/s0074-7742(08)60668-6

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  2 in total

1.  Unc-1: a stomatin homologue controls sensitivity to volatile anesthetics in Caenorhabditis elegans.

Authors:  S Rajaram; M M Sedensky; P G Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 2.  Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs.

Authors:  Donard S Dwyer; Eric Aamodt; Bruce Cohen; Edgar A Buttner
Journal:  Front Pharmacol       Date:  2014-07-28       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.